A detailed history of Tectonic Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tectonic Advisors LLC holds 75,706 shares of GILD stock, worth $6.92 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
75,706
Previous 65,748 15.15%
Holding current value
$6.92 Million
Previous $4.51 Million 40.69%
% of portfolio
0.42%
Previous 0.33%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$66.59 - $83.99 $663,103 - $836,372
9,958 Added 15.15%
75,706 $6.35 Million
Q2 2024

Aug 02, 2024

BUY
$63.15 - $72.88 $637,625 - $735,869
10,097 Added 18.14%
65,748 $4.51 Million
Q1 2024

May 07, 2024

BUY
$71.58 - $87.29 $414,161 - $505,059
5,786 Added 11.6%
55,651 $4.08 Million
Q4 2023

Jan 17, 2024

BUY
$73.27 - $83.09 $212,702 - $241,210
2,903 Added 6.18%
49,865 $4.04 Million
Q3 2023

Oct 23, 2023

BUY
$73.94 - $80.67 $386,040 - $421,178
5,221 Added 12.51%
46,962 $3.52 Million
Q2 2023

Jul 13, 2023

BUY
$76.01 - $86.7 $349,874 - $399,080
4,603 Added 12.39%
41,741 $3.22 Million
Q1 2023

Apr 25, 2023

BUY
$77.31 - $88.08 $532,433 - $606,606
6,887 Added 22.77%
37,138 $3.08 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $219,241 - $314,755
3,518 Added 13.16%
30,251 $2.6 Million
Q3 2022

Nov 08, 2022

BUY
$59.54 - $68.01 $347,713 - $397,178
5,840 Added 27.95%
26,733 $1.65 Million
Q2 2022

Aug 11, 2022

BUY
$57.72 - $65.01 $286,175 - $322,319
4,958 Added 31.11%
20,893 $1.29 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $208,106 - $260,779
3,593 Added 29.11%
15,935 $947,000
Q4 2021

Feb 02, 2022

BUY
$64.88 - $73.64 $398,752 - $452,591
6,146 Added 99.19%
12,342 $896,000
Q3 2021

Nov 02, 2021

BUY
$67.69 - $73.03 $123,263 - $132,987
1,821 Added 41.62%
6,196 $433,000
Q2 2021

Jul 22, 2021

BUY
$63.47 - $69.35 $50,649 - $55,341
798 Added 22.31%
4,375 $301,000
Q1 2021

May 18, 2021

BUY
$60.0 - $68.46 $214,620 - $244,881
3,577 New
3,577 $232,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Tectonic Advisors LLC Portfolio

Follow Tectonic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tectonic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tectonic Advisors LLC with notifications on news.